g.valckenaere

TL3 Regular · Lausanne, CH

Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.

Joined 4 January 2025 · last posted 3d · groups: pharmacists

124 posts, newest first. Showing up to 150.

Coming back to: Time to steady state after a dose increase Replied, post #110 · Pharmacology › Pharmacokinetics · 25 Jul 2026 · 24 likes Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #61 · Analytics › HPLC & UHPLC · 23 Jul 2026 · 12 likes Post #59 and I disagree about the size of the effect, not about the direction. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #77 · Compounds › Retatrutide · 20 Jul 2026 · 23 likes Post #73 and I disagree about the size of the effect, not about the direction. No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3…
Spreadsheets: an appreciation — what changed since Replied, post #106 · Lounge › Off topic · 20 Jul 2026 · 0 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #60 · Compounds › Repair & healing peptides · 15 Jul 2026 · 33 likes Building on post #57 rather than restating it. BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is not a dismissal — it is the state…
Pooling trials with different estimands Replied, post #93 · Evidence › Meta-analyses · 13 Jul 2026 · 15 likes Where I part company with post #91, and it is a narrow parting. Where the pooling trials with different estimands discussion usually stalls is that nobody wants to say…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #13 · Access › Insurance & coverage · 9 Jul 2026 · 0 likes Post #9 and I disagree about the size of the effect, not about the direction. What does not work: describing how the decision made you feel, however justified. The…
Restarting after a long gap: what the labelling implies Replied, post #14 · Practice › Dosing & titration · 6 Jul 2026 · 17 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Reused chromatograms across lots: how to spot it Replied, post #55 · Analytics › COA interpretation · 6 Jul 2026 · 0 likes Coming back to post #51, because the follow-up matters more than the original answer. Counterpoint on reused chromatograms across lots, offered without confidence: the…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #30 · Practice › Side effects · 4 Jul 2026 · 1 like Small methodological point on Muscle cramps: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #11 · Practice › Interactions · 4 Jul 2026 · 9 likes On Antibiotics, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Asking a follow-up: new topic or new reply? Replied, post #30 · Start Here › How to Ask · 29 Jun 2026 · 0 likes Post #28 and I disagree about the size of the effect, not about the direction. Questions you cannot explain: "I cannot say why I am asking this, but is this compound…
Personal or family history of medullary thyroid carcinoma Replied, post #27 · Safety › Contraindications · 29 Jun 2026 · 2 likes Answering the question post #25 raises rather than the one it answers. Somebody's condition being on a list does not settle the decision, and somebody's condition being…
About the Shortages category Replied, post #4 · Access › Shortages · 23 Jun 2026 · 27 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
Personal or family history of medullary thyroid carcinoma Replied, post #8 · Safety › Contraindications · 23 Jun 2026 · 0 likes Adding a data point of agreement rather than a data point.
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #27 · Access › International · 21 Jun 2026 · 13 likes Post #25 put the caveat in the right place and I want to underline it. Where a jurisdiction has published guidance for clinicians, that document usually answers the…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #13 · Pharmacology › Receptor biology · 8 Jun 2026 · 4 likes This follows post #12 rather than contradicting it. The claim about receptor desensitisation upthread is stronger than its source supports. I have read the source. The…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #92 · Practice › Reconstitution · 6 Jun 2026 · 7 likes Swirling until fully clear before drawing is worth the extra minute. A partially dissolved preparation is not uniform and the first dose out of it is not the same as…
Peak-to-trough ratio at steady state for a weekly agent Replied, post #14 · Pharmacology › Pharmacokinetics · 31 May 2026 · 0 likes Steady state is approached in roughly four to five half-lives. For a compound with a week-long half-life that is four to five weeks, which is where the escalation…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #71 · Practice › Reconstitution · 25 May 2026 · 16 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. I have…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #17 · Sourcing › Independent verification · 23 May 2026 · 1 like A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. On balance I think that is right, and I…
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #15 · Practice › Administration · 21 May 2026 · 0 likes Marking my place. If it changes for me I will come back and say so.
Second pass at: Absence of evidence and evidence of absence Replied, post #6 · Research Methods › Statistics · 20 May 2026 · 27 likes Post #4 describes the usual case. This is about the unusual one. Percentages of small denominators should be reported with the denominator. Two out of three is not…
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #6 · Evidence › Meta-analyses · 14 May 2026 · 0 likes The most useful thing anyone has posted about Risk-of-bias tools in this category was a table of what had been measured and by whom. That is what I would want again.
The anatomy of a question that gets answered within an hour Replied, post #41 · Start Here › How to Ask · 10 May 2026 · 0 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
A checklist for reading a certificate in under two minutes Replied, post #16 · Analytics › COA interpretation · 6 May 2026 · 16 likes Asking for the batch record rather than the certificate is a reasonable request and the response to it is informative whichever way it goes. If that is already…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #25 · Compounds › Tirzepatide · 6 May 2026 · 5 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
[2026 update] Composite endpoints and the component doing the work Replied, post #81 · Evidence › Trials · 22 Apr 2026 · 0 likes Careful with the language on Composite endpoints. "Not detected" and "not present" are different findings and the first is a statement about the method.
Follow-up: State-level differences that actually matter Replied, post #97 · Regional › North America · 9 Apr 2026 · 0 likes The public assessment documents published at approval are free, detailed and largely unread here. It took me longer than it should have to see that.
The "under review" status pill and when a moderator applies it Replied, post #58 · Evidence › Preprints · 6 Apr 2026 · 3 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #41 · Analytics › Mass spectrometry · 30 Mar 2026 · 4 likes Adding the measurement that post #38 says would settle it. Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong,…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #8 · Analytics › Mass spectrometry · 14 Mar 2026 · 14 likes Trifluoroacetate adducts are common in material purified with TFA and are one reason a mass spectrum from a peptide can look busier than expected. I have seen it go…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #55 · Practice › Side effects · 11 Mar 2026 · 5 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #128 · Practice › Interactions · 9 Mar 2026 · 29 likes Genuine question rather than a rhetorical one: has anyone here actually observed Warfarin and altered intake, as opposed to read about it? The thread is long and I…
Constipation management, with a dietitian's contribution Replied, post #37 · Practice › Side effects · 6 Mar 2026 · 14 likes Where the constipation management discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
Cost per delivered dose, which is the number that matters Replied, post #49 · Access › Pricing · 17 Feb 2026 · 0 likes Post #45 describes the usual case. This is about the unusual one. Nothing here is financial advice and none of it is a route to a transaction. That is the practical…
A widely repeated interaction claim that turns out to be unsupported — what changed since Started this topic · Practice › Interactions · 16 Feb 2026 · 1 like A widely repeated interaction claim that turns out to be unsupported — what changed since Writing it up because I had to work it out twice and would rather nobody else…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #25 · Practice › Dosing & titration · 16 Feb 2026 · 17 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #133 · Analytics › COA interpretation · 16 Feb 2026 · 0 likes Coming back to post #131, because the follow-up matters more than the original answer. A chromatogram supplied as a small image is legible for peak shape and not for…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #90 · Documentation › Wiki requests · 15 Feb 2026 · 0 likes Building on post #87 rather than restating it. A page that would need to be rewritten every quarter is usually better as a topic with a good marked solution.
[2026 update] Confounding by indication, explained with a concrete example Replied, post #46 · Evidence › Study critique · 12 Feb 2026 · 0 likes A criticism that would apply equally to every trial in the field is worth stating once and is not a reason to discount a particular paper. If that is already documented…
[2026 update] What a purity-only report leaves out Replied, post #21 · Sourcing › Independent verification · 10 Feb 2026 · 0 likes Answering the question post #19 raises rather than the one it answers. It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #66 · Access › Pricing · 19 Jan 2026 · 0 likes Post #65 is the version of this I will quote in future. One addition. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates.…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #13 · Research Methods › Statistics · 15 Jan 2026 · 0 likes A methods point on Measurement error in home scales rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the…
Muscle cramps: the ordinary causes before the exotic ones Replied, post #20 · Practice › Side effects · 14 Jan 2026 · 2 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Alcohol: what is documented and what is folklore — the long version Replied, post #11 · Practice › Interactions · 12 Jan 2026 · 14 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #73 · Clinical › Special populations · 11 Jan 2026 · 0 likes Sensible. I would want the same detail before I acted on it either.
[2026 update] Availability by country, dated, with primary sources Replied, post #5 · Access › International · 26 Dec 2025 · 18 likes Customs practice varies between entry points within the same country, which is why two people in the same jurisdiction report different experiences honestly.
Heterogeneity as information rather than as a nuisance Replied, post #32 · Evidence › Meta-analyses · 20 Dec 2025 · 0 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
Angle of injection and whether 90 degrees is always right Replied, post #67 · Practice › Administration · 17 Dec 2025 · 31 likes Adding a data point of agreement rather than a data point.
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #23 · Safety › Contraindications · 11 Dec 2025 · 0 likes Everything in post #20 holds. The case it does not cover is the one I have. My understanding of Severe gastroparesis is a few years old and may have been superseded. If…
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #34 · Analytics › Method validation · 11 Dec 2025 · 1 like I had written a reply contradicting post #30 and deleted it. Here is what survived. The most useful single question about a method: what would it fail to detect? Every…
Tracking a preprint to publication: a worked example Replied, post #52 · Evidence › Preprints · 5 Dec 2025 · 17 likes I read post #48 twice before replying, because I had assumed the opposite. How to cite a preprint: author last name, first initial, et al. Title. Server name…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #53 · Compounds › Oral incretins · 20 Nov 2025 · 0 likes Taking the oral product with more water than instructed reduces absorption rather than helping it. That is counter-intuitive and it is one of the few dosing…
Pen dose counters: what a click does and does not guarantee Replied, post #106 · Devices › Pens & autoinjectors · 19 Nov 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
What a regulator's shortage notice actually authorises — what changed since Replied, post #19 · Sourcing › Regulatory · 19 Nov 2025 · 0 likes Post #16 is the version of this I will quote in future. One addition. An indication approved for one age range does not extend to another, and paediatric extensions are…
Constipation management, with a dietitian's contribution Replied, post #3 · Practice › Side effects · 17 Nov 2025 · 29 likes Summarising the constipation management thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it,…
Second pass at: The mass-error checker and its intended scope Replied, post #56 · Data & Tools › Calculators · 5 Nov 2025 · 26 likes On mass-error checker, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #76 · Practice › Reconstitution · 2 Nov 2025 · 7 likes For anyone finding this later: the short answer on Over-dilution is that it depends on one thing, and the rest of the thread is people identifying which thing.
The anatomy of a question that gets answered within an hour — the long version Replied, post #42 · Start Here › How to Ask · 30 Oct 2025 · 11 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
Sleep tracking data and its considerable limitations Replied, post #115 · Wellbeing › Sleep · 28 Oct 2025 · 14 likes Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that pattern. Sleep can worsen if nighttime waking is…
Sleep quality changes during weight loss — what changed since Replied, post #30 · Wellbeing › Sleep · 17 Oct 2025 · 0 likes Taking post #29 at face value and following it one step further. Where sleep worsened at the same time as an escalation and improved afterwards, that sequence is worth…
Thyroid function tests during substantial weight change Replied, post #81 · Clinical › Bloodwork · 2 Oct 2025 · 13 likes Post #79 is the version of this I will quote in future. One addition. Rate of change is frequently more informative than absolute value, and it is only available if the…
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #13 · Analytics › HPLC & UHPLC · 27 Sep 2025 · 0 likes Trifluoroacetic acid at 0.1 per cent is the near-universal ion-pairing additive for this work, and it also raises the baseline at 214 nanometres. That is why the same…
What pooling buys you and what it destroys Replied, post #27 · Evidence › Meta-analyses · 23 Sep 2025 · 1 like The reason pooling buys keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
Payment method and the leverage it gives you, ranked Replied, post #49 · Sourcing › Payments · 21 Sep 2025 · 24 likes Cryptocurrency for payment: offers less fraud protection than credit cards and is final like bank transfer. Advantage: no geographic restrictions and no intermediary…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #132 · Data & Tools › Datasets · 11 Sep 2025 · 14 likes Narrowing post #129, because the general version has more than one answer. The number people quote for Aggregated purity results across four is a central estimate…
Pinch or no pinch, and how needle length changes the answer Replied, post #46 · Practice › Administration · 4 Sep 2025 · 17 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #18 · Analytics › Method validation · 27 Aug 2025 · 18 likes On LOD and LOQ I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads…
A ten-fold dose error caught before injection Replied, post #84 · Devices › Syringes & needles · 18 Aug 2025 · 0 likes The failure mode on ten-fold dose error caught is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #16 · Analytics › Method validation · 1 Aug 2025 · 0 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
Mood changes: monitoring, and when to involve a professional Replied, post #3 · Wellbeing › Mental health · 1 Jul 2025 · 6 likes Being honest with a clinician about mood is the thing people most often avoid and most often report was worth doing.
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #61 · Compounds › Cagrilintide & amylin analogues · 27 Jun 2025 · 2 likes Offering a way to settle cagrisema phase 2 paper rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is…
Repeatability versus intermediate precision Replied, post #65 · Analytics › Method validation · 26 Jun 2025 · 4 likes No notes. Posting so the count is not one.
Repeatability versus intermediate precision Replied, post #14 · Analytics › Method validation · 18 Jun 2025 · 31 likes Worth separating two things that post #11 runs together. On repeatability versus intermediate precision, the part that usually goes wrong is that the question is asked…
Sodium, potassium and magnesium when intake drops Replied, post #18 · Nutrition & Training › Hydration & electrolytes · 16 Jun 2025 · 0 likes Magnesium supplementation is widely recommended in this space with very little supporting evidence for the indications it is recommended for.
Revisiting: German, French and Dutch differences, compared Replied, post #33 · Regional › European Union · 14 Jun 2025 · 0 likes Post #31 describes the usual case. This is about the unusual one. Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular…
Second pass at: Sleep tracking data and its considerable limitations Started this topic · Wellbeing › Sleep · 12 Jun 2025 · 10 likes Posting this under the heading it deserves: Second pass at: Sleep tracking data and its considerable limitations Everything below is what sits behind that. A…
What this community means by "a source", in practical terms Replied, post #3 · Start Here › Welcome · 9 Jun 2025 · 17 likes Fair, and the limits you put on it are the part I will remember.
A report I filed that turned out to be wrong, and the correction Replied, post #78 · Sourcing › Vendor reports · 30 May 2025 · 4 likes On post #74 — agreed on the reasoning, with one qualification. Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate…
Lean mass preservation: what the evidence supports Replied, post #28 · Outcomes › Body composition · 22 May 2025 · 0 likes Confirming post #25 from a second method, which matters more than confirming it from a second person. If you are new and reading this thread for the answer to lean mass…
A claim built entirely on a subgroup analysis Replied, post #46 · Evidence › Study critique · 21 May 2025 · 5 likes Adding the measurement that post #43 says would settle it. Source for the claim built figure, since it was asked for. It is in the discussion rather than the abstract,…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #154 · Sourcing › Regulatory · 17 May 2025 · 5 likes Research-use-only labelling has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #86 · Sourcing › Independent verification · 13 May 2025 · 10 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
State-level differences that actually matter Replied, post #4 · Regional › North America · 5 May 2025 · 27 likes The number people quote for state-level differences is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
Dizziness on standing: the ordinary explanation first Replied, post #20 · Nutrition & Training › Hydration & electrolytes · 28 Apr 2025 · 20 likes Having read the whole dizziness on standing thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a…
Validating a calculator against hand arithmetic — what changed since Replied, post #29 · Data & Tools › Calculators · 23 Apr 2025 · 12 likes Post #27 is right about the mechanism and I think understates the practical bit. I read the earlier replies on Validating a calculator against hand twice before writing…
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #36 · Compounds › Other compounds · 28 Mar 2025 · 0 likes Post #35 and I disagree about the size of the effect, not about the direction. Naming conventions for research peptides cause confusion because suppliers do not follow…
Sequence verification for an obscure compound: how it is done Replied, post #2 · Compounds › Other compounds · 27 Mar 2025 · 0 likes The opening post is right about the mechanism and I think understates the practical bit. The number people quote for sequence verification is a central estimate…
When "no data" is the complete and final answer Replied, post #128 · Compounds › Other compounds · 25 Mar 2025 · 26 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Coming back to: What published stability data actually covers, and what it does not Replied, post #10 · Practice › Storage & stability · 24 Mar 2025 · 2 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #13 · Practice › Administration · 22 Mar 2025 · 16 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. Happy…
Validating a method you did not develop — does this still hold? Replied, post #145 · Analytics › Method validation · 21 Mar 2025 · 2 likes Post #144 is the version of this I will quote in future. One addition. System suitability is the ongoing evidence that a validated method is still performing.…
Retatrutide dose escalation in the published trials Replied, post #32 · Compounds › Retatrutide · 20 Mar 2025 · 28 likes No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this compound is either a misreading or an invention, and the honest…
Charge states for a 4 kDa peptide, worked through Replied, post #76 · Analytics › Mass spectrometry · 11 Mar 2025 · 0 likes Taking post #73 at face value and following it one step further. Resolution: "high resolution" commonly means The interesting part of this is the exception, and I do…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #77 · Pharmacology › Receptor biology · 11 Mar 2025 · 5 likes I had written a reply contradicting post #75 and deleted it. Here is what survived. Biased agonism was covered in the wiki last year and the page has a review date on…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #93 · Compounds › Semaglutide · 9 Mar 2025 · 13 likes I have been on both sides of the published dose-response for semaglutide argument in this category within eighteen months, which should tell you how strong the evidence…
Consistent declarations and why they matter more than clever ones Replied, post #150 · Sourcing › Logistics · 8 Mar 2025 · 24 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
Revisiting: Filter needles: when they help and what they cost you Replied, post #4 · Devices › Syringes & needles · 4 Mar 2025 · 3 likes Building on post #3 rather than restating it. Safety-engineered needles are worth using if you have children or anyone else in the house, and the retraction mechanism…
Follow-up: Attributing a new peak: degradation product or excipient? Replied, post #5 · Analytics › Impurities & related substances · 15 Feb 2025 · 0 likes Incomplete deprotection leaves a protecting group attached, raising the mass substantially and usually pushing retention much later. A late-eluting peak on a peptide…
Consistent declarations and why they matter more than clever ones Replied, post #25 · Sourcing › Logistics · 12 Feb 2025 · 13 likes Useful. I have added it to my own notes with the date on it.
What a seizure notice actually says Replied, post #29 · Sourcing › Logistics · 31 Jan 2025 · 2 likes The reason seizure notice is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #19 · Practice › Reconstitution · 24 Jan 2025 · 4 likes Coming back to post #16, because the follow-up matters more than the original answer. Preservative effectiveness is tested against a defined microbial challenge under…
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #71 · Compounds › Semaglutide · 2 Jan 2025 · 28 likes Everything in post #67 holds. The case it does not cover is the one I have. The oral formulation is a genuinely different pharmaceutical problem from the injectable and…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #65 · Compounds › Oral incretins · 27 Dec 2024 · 26 likes On post #63 — agreed on the reasoning, with one qualification. Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel.…
Oxidation pathways for methionine and tryptophan Started this topic · Analytics › Impurities & related substances · 24 Dec 2024 · 24 likes Posting this under the heading it deserves: Oxidation pathways for methionine and tryptophan Everything below is what sits behind that. Working notes on oxidation…
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #35 · Compounds › Semaglutide · 24 Dec 2024 · 2 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
Coming back to: When to suspect the method rather than the sample Replied, post #93 · Analytics › Method validation · 18 Dec 2024 · 6 likes Post #90 is right about the mechanism and I think understates the practical bit. Accuracy: the method measures what you intend to measure. For purity methods, this is…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #23 · Devices › Cold chain · 17 Dec 2024 · 30 likes Post #19 describes the usual case. This is about the unusual one. Two things can be true about Domestic fridge temperature mapping at once: the mechanism is plausible…
Coming back to: When to suspect the method rather than the sample Replied, post #78 · Analytics › Method validation · 15 Dec 2024 · 0 likes That is clearer than the version I had in my head. Thank you.
Body image changing more slowly than the body Replied, post #30 · Wellbeing › Mental health · 14 Dec 2024 · 0 likes Taking post #27 at face value and following it one step further. Small methodological point on body image: repeating a measurement is cheap and resolves most of what is…
EMA product information as a primary source — does this still hold? Replied, post #144 · Regional › European Union · 19 Nov 2024 · 15 likes Seconded. It reads as careful rather than confident, which is the right register.
Merging two pages that cover the same ground — the long version Replied, post #10 · Documentation › Wiki requests · 17 Nov 2024 · 0 likes If a request is declined, the reasoning is written down, and it is worth reading because it usually describes a better version of the same idea. I have left out the…
US compounding rules and how they changed Replied, post #40 · Regional › North America · 25 Oct 2024 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
Blind submission and why it changes minds Replied, post #79 · Sourcing › Independent verification · 5 Oct 2024 · 26 likes Taking post #78 at face value and following it one step further. The honest answer on blind submission is that it depends, and the useful part is the list of what it…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #105 · Sourcing › Independent verification · 3 Oct 2024 · 0 likes Cross-checking one lot with two services independently is the cleanest test available and is rarely done because it costs twice as much. If it helps: the failure mode…
When a red flag was a misunderstanding, and the retraction Replied, post #23 · Sourcing › Red flags · 26 Sep 2024 · 5 likes Testimonials without a lot, a date, a method or a service are not evidence and are not a red flag either. They are simply not evidence.
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #38 · Practice › Administration · 18 Sep 2024 · 11 likes Second this, and I would have said it less carefully.
Promotion criteria, and the one that stops most nominations Replied, post #57 · Documentation › Doc review · 9 Sep 2024 · 8 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage. I would put the burden of proof on…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #34 · Evidence › Journal club · 4 Sep 2024 · 10 likes What would change my mind on SURPASS-2 is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than…
The C-cell question: rodent findings and their human context — what changed since Replied, post #21 · Compounds › Semaglutide · 25 Aug 2024 · 24 likes The claim about c-cell question upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
Cold packs, phase-change material, and what survives ten days Replied, post #135 · Sourcing › Logistics · 23 Jul 2024 · 0 likes Thank you — that answers what I came here to find out.
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #94 · Practice › Dosing & titration · 9 Jul 2024 · 10 likes The bit of Splitting a weekly dose that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the…
How this community labels and discusses unrefereed work Replied, post #60 · Evidence › Preprints · 4 Jul 2024 · 13 likes Taking post #57 at face value and following it one step further. I think the community labels question is answerable and has not been answered, which is a more…